Serial (1)H-MRS of thalamus during deep brain stimulation of bilateral globus pallidus internus for primary generalized dystonia. 2008

Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
Department of Neurosurgery, Neurological Institute, Tokyo Women's Medical University, Tokyo, Japan. m_chernov@yahoo.com

BACKGROUND The physiological mechanisms of deep brain stimulation (DBS) are not completely clear. Our understanding of them may be facilitated with the use of proton magnetic resonance spectroscopy ((1)H-MRS). METHODS Serial (1)H-MRS of both thalami was performed during the course of DBS of bilateral globus pallidus internus in a patient with primary generalized dystonia. RESULTS Two days after microelectrode implantation, a pulse frequency of 185 Hz was applied for stimulation. It resulted in relief of symptoms and a decrease of Burke-Fahn-Marsden dystonia rating scale (BFMDRS) scores, and was accompanied by a prominent increase of N-acetylaspartate (NAA)/choline-containing compounds (Cho) ratio, a mild increase of NAA/creatine (Cr) ratio, and a moderate decrease of Cho/Cr ratio. Two weeks later, for a search of the optimal stimulation mode, the pulse frequency was switched to 60 Hz, which resulted in clinical deterioration and significant increase of BFMDRS scores. At that time, all investigated (1)H-MRS-detected metabolic parameters had nearly returned to the pretreatment levels. CONCLUSIONS Use of serial (1)H-MRS investigations of various brain structures during DBS in cases of movement disorders permits detailed evaluation of the treatment response, has a potential for its possible prediction, and may facilitate understanding of the physiological mechanisms of stimulation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002794 Choline A basic constituent of lecithin that is found in many plants and animal organs. It is important as a precursor of acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism. Bursine,Fagine,Vidine,2-Hydroxy-N,N,N-trimethylethanaminium,Choline Bitartrate,Choline Chloride,Choline Citrate,Choline Hydroxide,Choline O-Sulfate,Bitartrate, Choline,Chloride, Choline,Choline O Sulfate,Citrate, Choline,Hydroxide, Choline,O-Sulfate, Choline
D003401 Creatine An amino acid that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as CREATININE in the urine.
D005917 Globus Pallidus The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus. Paleostriatum,Pallidum,Pallidums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001224 Aspartic Acid One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. (+-)-Aspartic Acid,(R,S)-Aspartic Acid,Ammonium Aspartate,Aspartate,Aspartate Magnesium Hydrochloride,Aspartic Acid, Ammonium Salt,Aspartic Acid, Calcium Salt,Aspartic Acid, Dipotassium Salt,Aspartic Acid, Disodium Salt,Aspartic Acid, Hydrobromide,Aspartic Acid, Hydrochloride,Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate,Aspartic Acid, Magnesium (2:1) Salt,Aspartic Acid, Magnesium-Potassium (2:1:2) Salt,Aspartic Acid, Monopotassium Salt,Aspartic Acid, Monosodium Salt,Aspartic Acid, Potassium Salt,Aspartic Acid, Sodium Salt,Calcium Aspartate,Dipotassium Aspartate,Disodium Aspartate,L-Aspartate,L-Aspartic Acid,Magnesiocard,Magnesium Aspartate,Mg-5-Longoral,Monopotassium Aspartate,Monosodium Aspartate,Potassium Aspartate,Sodium Aspartate,Aspartate, Ammonium,Aspartate, Calcium,Aspartate, Dipotassium,Aspartate, Disodium,Aspartate, Magnesium,Aspartate, Monopotassium,Aspartate, Monosodium,Aspartate, Potassium,Aspartate, Sodium,L Aspartate,L Aspartic Acid
D013788 Thalamus Paired bodies containing mostly GRAY MATTER and forming part of the lateral wall of the THIRD VENTRICLE of the brain. Thalamencephalon,Thalamencephalons
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
July 2004, Tennessee medicine : journal of the Tennessee Medical Association,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
January 2014, Medical journal of the Islamic Republic of Iran,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
July 2007, Parkinsonism & related disorders,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
February 2005, The New England journal of medicine,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
October 2008, Movement disorders : official journal of the Movement Disorder Society,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
July 2013, Movement disorders : official journal of the Movement Disorder Society,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
September 2014, Movement disorders clinical practice,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
July 2013, Movement disorders : official journal of the Movement Disorder Society,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
January 2011, Stereotactic and functional neurosurgery,
Mikhail F Chernov, and Taku Ochiai, and Takaomi Taira, and Yuko Ono, and Ryoichi Nakamura, and Yoshihiro Muragaki, and Hiroshi Iseki, and Tomokatsu Hori, and Kintomo Takakura
November 1997, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!